152 related articles for article (PubMed ID: 36055007)
1. Clinicopathological analysis of recurrence and progression of low-grade papillary urothelial carcinoma of the urinary bladder: Predicting the outcome.
Bahmad HF; Lopez O; Moreno JCA; Lopez K; Malik F; Salami A; Nieder AM; Omarzai Y; Poppiti RJ
Ann Diagn Pathol; 2022 Dec; 61():152030. PubMed ID: 36055007
[TBL] [Abstract][Full Text] [Related]
2. Cytologic diagnosis of low-grade papillary urothelial neoplasms (low malignant potential and low-grade carcinoma) in the context of the 1998 WHO/ISUP classification.
Whisnant RE; Bastacky SI; Ohori NP
Diagn Cytopathol; 2003 Apr; 28(4):186-90. PubMed ID: 12672093
[TBL] [Abstract][Full Text] [Related]
3. A retrospective study on expression and clinical significance of PHH3, Ki67 and P53 in bladder exophytic papillary urothelial neoplasms.
Qi G; Liu J; Tao S; Fan W; Zheng H; Wang M; Yang H; Liu Y; Liu H; Zhou F
PeerJ; 2023; 11():e15675. PubMed ID: 37456895
[TBL] [Abstract][Full Text] [Related]
4. Low-grade papillary urothelial carcinoma of the urinary bladder: a clinicopathologic analysis of a post-World Health Organization/International Society of Urological Pathology classification cohort from a single academic center.
Miyamoto H; Brimo F; Schultz L; Ye H; Miller JS; Fajardo DA; Lee TK; Epstein JI; Netto GJ
Arch Pathol Lab Med; 2010 Aug; 134(8):1160-3. PubMed ID: 20670136
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of MUC1 and P53 expressions in noninvasive papillary urothelial neoplasms of bladder, their relationship with tumor grade and role in the differential diagnosis.
Kaymaz E; Ozer E; Unverdi H; Hucumenoglu S
Indian J Pathol Microbiol; 2017; 60(4):510-514. PubMed ID: 29323063
[TBL] [Abstract][Full Text] [Related]
6. Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.
Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Tariciotti P; Rizzo G; Buscarini M; Vermiglio M
Arch Ital Urol Androl; 2017 Dec; 89(4):272-276. PubMed ID: 29473376
[TBL] [Abstract][Full Text] [Related]
7. Papillary Urothelial Neoplasm of Low Malignant Potential (PUNLMP) After Initial TUR-BT: Comparative Analyses with Noninvasive Low-Grade Papillary Urothelial Carcinoma (LGPUC).
Kim JK; Moon KC; Jeong CW; Kwak C; Kim HH; Ku JH
J Cancer; 2017; 8(15):2885-2891. PubMed ID: 28928878
[No Abstract] [Full Text] [Related]
8. Histopathological evaluation of urothelial carcinomas in transurethral resection urinary bladder tumor specimens: eight years of single center experience.
Koyuncuer A
Asian Pac J Cancer Prev; 2015; 16(7):2871-7. PubMed ID: 25854375
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection.
Chang WC; Chang YH; Pan CC
Am J Surg Pathol; 2012 Mar; 36(3):454-61. PubMed ID: 22261706
[TBL] [Abstract][Full Text] [Related]
10. International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer. Working Group 2: Grading of Mixed Grade, Invasive Urothelial Carcinoma Including Histologic Subtypes and Divergent Differentiations, and Non-Urothelial Carcinomas.
Paner GP; Kamat A; Netto GJ; Samaratunga H; Varma M; Bubendorf L; van der Kwast TH; Cheng L;
Am J Surg Pathol; 2024 Jan; 48(1):e11-e23. PubMed ID: 37382156
[TBL] [Abstract][Full Text] [Related]
11. CLINICO-PATHOLOGICAL PATTERN, CLASSIFICATION AND STAGING OF URINARY BLADDER CARCINOMAS--A FIVE YEARS EXPERIENCE AT A TERTIARY CARE HOSPITAL IN CENTRAL PUNJAB.
Naeem A; Naseem N; Anwar S; Butt S; Nagi AH
J Ayub Med Coll Abbottabad; 2015; 27(1):131-4. PubMed ID: 26182758
[TBL] [Abstract][Full Text] [Related]
12. MOLECULAR CHARACTERISTICS OF THE HETEROGENEITY OF NON-INVASIVE PAPILLARY UROTHELIAL CARCINOMAS AND THE MARKERS OF THEIR RECURRENCE.
Kajaia D; Kochiashvili D; Muzashvili T; Gachechiladze M; Burkadze G
Georgian Med News; 2021; (316-317):178-184. PubMed ID: 34511468
[TBL] [Abstract][Full Text] [Related]
13. Reduced immunohistochemical PTEN staining is associated with higher progression rate and recurrence episodes in non-invasive low-grade papillary urothelial carcinoma of the bladder.
Kulac I; Arslankoz S; Netto GJ; Ertoy Baydar D
Virchows Arch; 2018 Jun; 472(6):969-974. PubMed ID: 29368083
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of the 2004 WHO/ISUP classification for prediction of recurrence, progression, and cancer-specific mortality of non-muscle-invasive urothelial tumors of the urinary bladder: a clinicopathologic study of 1,515 cases.
Pan CC; Chang YH; Chen KK; Yu HJ; Sun CH; Ho DM
Am J Clin Pathol; 2010 May; 133(5):788-95. PubMed ID: 20395527
[TBL] [Abstract][Full Text] [Related]
15. Young population bladder neoplasms.
Çivi Çetin K; Öner S; Erdoğan B; Simşek G; Sezer M
Eur Rev Med Pharmacol Sci; 2023 Nov; 27(21):10454-10461. PubMed ID: 37975369
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. World/Health Organization/Internattional Society of Urologic Pathology.
Alsheikh A; Mohamedali Z; Jones E; Masterson J; Gilks CB
Mod Pathol; 2001 Apr; 14(4):267-72. PubMed ID: 11301341
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of minor high grade component in non-invasive papillary urothelial carcinoma of urinary bladder: (A study of 273 consecutive cases over a period of 3 years).
Syed M; Mushtaq S; Loya A; Hassan U; Mir K; Hussain M; Hameed M; Sheikh UN
Ann Diagn Pathol; 2023 Apr; 63():152079. PubMed ID: 36549142
[TBL] [Abstract][Full Text] [Related]
18. Histological grading of papillary urothelial carcinoma of the bladder: prognostic value of the 1998 WHO/ISUP classification system and comparison with conventional grading systems.
Oosterhuis JW; Schapers RF; Janssen-Heijnen ML; Pauwels RP; Newling DW; ten Kate F
J Clin Pathol; 2002 Dec; 55(12):900-5. PubMed ID: 12461053
[TBL] [Abstract][Full Text] [Related]
19. Recurrence and progression in low grade papillary urothelial tumors.
Holmäng S; Hedelin H; Anderström C; Holmberg E; Busch C; Johansson SL
J Urol; 1999 Sep; 162(3 Pt 1):702-7. PubMed ID: 10458347
[TBL] [Abstract][Full Text] [Related]
20. Assessing the Impact of the Absence of Detrusor Muscle in Ta Low-grade Urothelial Carcinoma of the Bladder on Recurrence-free Survival.
Mastroianni R; Brassetti A; Krajewski W; Zdrojowy R; Salhi YA; Anceschi U; Bove AM; Carbone A; De Nunzio C; Fuschi A; Ferriero M; Nacchia A; Pastore AL; Tema G; Tuderti G; Gallucci M; Simone G
Eur Urol Focus; 2021 Nov; 7(6):1324-1331. PubMed ID: 32900676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
